Do baby sunscreens require FDA OTC compliance in the U.S., and what does that involve?

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

• In the U.S., baby sunscreens are regulated as over-the-counter (OTC) drugs by the FDA, requiring compliance with the sunscreen monograph.
• This involves facility registration (FPL), product listing with the FDA, and ensuring formulations meet monograph standards for active ingredients and concentrations.
• Key testing includes SPF efficacy, water resistance, stability under temperature and light, and microbial limits to ensure safety.
• Labeling must feature a Drug Facts panel, child-resistant packaging (e.g., CR caps), and appropriate warnings for sun protection.
• As an OEM/ODM manufacturer, we support clients through formulation development, sampling, and documentation preparation.
• MOQ typically starts at 5,000 to 10,000 units, depending on packaging complexity and material sourcing.
• Sampling timeline is 4-6 weeks for initial prototypes, including formula adjustments and compatibility tests with packaging.
• Production lead time post-approval is 8-12 weeks, covering batch manufacturing, QA checks for consistency, and assembly of compliance documents like test reports and certificates.
• We coordinate with third-party labs for required testing and assist with file submissions, but regulatory approval remains the client’s responsibility.